ADMA Biologics Ownership 2024 | Who Owns ADMA Biologics Now?
Institutional Ownership
77.98%
Insider Ownership
2.58%
Retail Ownership
19.44%
Institutional Holders
243.00
ADMA Biologics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 8.15% | 0.00% | 18,644,711 | 445,434 | 2.45% | 208,447,868 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.34% | 0.00% | 14,516,652 | 1,827,258 | 14.40% | 162,296,170 | Jun 30, 2024 |
| INVESCO LTD. | 5.75% | 0.03% | 13,170,736 | 5,366,509 | 68.76% | 147,248,828 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 3.90% | 0.03% | 8,925,138 | -1,536,238 | -14.68% | 99,783,044 | Jun 30, 2024 |
| STATE STREET CORP | 3.52% | 0.00% | 8,059,930 | -2,493,423 | -23.63% | 90,110,017,000 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 2.98% | 0.07% | 6,824,517 | 1,442,799 | 26.81% | 76,298,100 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 2.65% | 0.04% | 6,054,317 | -1,074,194 | -15.07% | 67,687,279 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.29% | 0.01% | 5,243,996 | 437,890 | 9.11% | 58,638,890 | Jun 30, 2024 |
| AWM INVESTMENT COMPANY, INC. | 2.23% | 7.70% | 5,097,625 | -617,257 | -10.80% | 56,991,447 | Jun 30, 2024 |
| MORGAN STANLEY | 2.01% | 0.00% | 4,598,487 | 781,763 | 20.48% | 51,411,084 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.76% | 0.10% | 4,027,600 | 181,642 | 4.72% | 45,028,568 | Jun 30, 2024 |
| MAGNETAR FINANCIAL LLC | 1.62% | 0.87% | 3,712,258 | -947,120 | -20.33% | 41,503,044 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 1.48% | 0.08% | 3,382,174 | 35,707 | 1.07% | 37,812,705 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.38% | 0.01% | 3,157,960 | -440,076 | -12.23% | 35,304,684 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 1.33% | 0.02% | 3,044,175 | -8,269 | -0.27% | 34,033,876 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.32% | 0.33% | 3,028,667 | 447,743 | 17.35% | 33,860,497 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.21% | 0.74% | 2,771,000 | -3,662,369 | -56.93% | 30,979,780 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.13% | 0.05% | 2,582,135 | 575,100 | 28.65% | 28,868,269 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.94% | 0.00% | 2,152,121 | 377,001 | 21.24% | 24,060,713 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.91% | 0.00% | 2,076,328 | 2,015,404 | 3308.06% | 23,214,000 | Jun 30, 2024 |
ADMA Biologics's largest institutional shareholder is BLACKROCK INC., holding 8.15% of the company's total share outstanding, currently valued at $208.45M. The top 10 institutional shareholders own together 39.82% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STONEPINE CAPITAL MANAGEMENT, LLC | 0.82% | 19.20% | 1,870,000 | -1,556,882 | -45.43% | 20,906,600 | Jun 30, 2024 |
| AWM INVESTMENT COMPANY, INC. | 2.23% | 7.70% | 5,097,625 | -617,257 | -10.80% | 56,991,447 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.66% | 6.89% | 1,510,000 | -30,000 | -1.95% | 16,881,800 | Jun 30, 2024 |
| OPHIR ASSET MANAGEMENT PTY LTD | 0.80% | 3.63% | 1,831,330 | -1,597,987 | -46.60% | 20,474,269 | Jun 30, 2024 |
| MIURA GLOBAL MANAGEMENT, LLC | 0.13% | 3.27% | 300,000 | 300,000 | 100.00% | 3,354,000 | Jun 30, 2024 |
| MESIROW INSTITUTIONAL INVESTMENT MANAGEMENT, INC. | 0.77% | 1.72% | 1,755,455 | -853,827 | -32.72% | 19,625,987 | Jun 30, 2024 |
| EAM GLOBAL INVESTORS LLC | 0.29% | 1.66% | 660,989 | -110,574 | -14.33% | 7,389,857 | Jun 30, 2024 |
| VIRTUS INVESTMENT ADVISERS, INC. | 0.07% | 1.49% | 157,268 | - | - | 1,758,256 | Jun 30, 2024 |
| OBERWEIS ASSET MANAGEMENT INC/ | 0.89% | 1.40% | 2,040,700 | -750,000 | -26.88% | 22,815,026 | Jun 30, 2024 |
| SEMANTEON CAPITAL MANAGEMENT, LP | 0.05% | 0.87% | 110,509 | -89,576 | -44.77% | 1,235,491 | Jun 30, 2024 |
| MAGNETAR FINANCIAL LLC | 1.62% | 0.87% | 3,712,258 | -947,120 | -20.33% | 41,503,044 | Jun 30, 2024 |
| RICE HALL JAMES & ASSOCIATES, LLC | 0.51% | 0.78% | 1,157,255 | -49,244 | -4.08% | 12,938,111 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.21% | 0.74% | 2,771,000 | -3,662,369 | -56.93% | 30,979,780 | Jun 30, 2024 |
| EAM INVESTORS, LLC | 0.16% | 0.68% | 374,977 | -247,109 | -39.72% | 4,192,243 | Jun 30, 2024 |
| CLARIVEST ASSET MANAGEMENT LLC | 0.25% | 0.66% | 575,251 | 6,026 | 1.06% | 6,431,307 | Jun 30, 2024 |
| VERDAD ADVISERS, LP | 0.02% | 0.63% | 49,018 | 49,018 | 100.00% | 548,021 | Jun 30, 2024 |
| VIRTUS FUND ADVISERS, LLC | 0.01% | 0.62% | 14,058 | 713 | 5.34% | 157,168 | Jun 30, 2024 |
| GLOBEFLEX CAPITAL L P | 0.20% | 0.55% | 467,772 | -10,374 | -2.17% | 5,229,691 | Jun 30, 2024 |
| OPTIONS SOLUTIONS, LLC | 0.03% | 0.50% | 75,886 | 17,318 | 29.57% | 848,405 | Jun 30, 2024 |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 0.25% | 0.50% | 566,930 | -62,970 | -10.00% | 6,338,277 | Jun 30, 2024 |
The largest ADMA Biologics shareholder by % of total assets is STONEPINE CAPITAL MANAGEMENT, LLC. The company owns 1.87M shares of ADMA Biologics (ADMA), representing 19.20% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| INVESCO LTD. | 5.75% | 0.03% | 13,170,736 | 5,366,509 | 68.76% | 147,248,828 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.91% | 0.00% | 2,076,328 | 2,015,404 | 3308.06% | 23,214,000 | Jun 30, 2024 |
| FMR LLC | 0.82% | 0.00% | 1,875,950 | 1,871,824 | 45366.55% | 20,973,121 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.34% | 0.00% | 14,516,652 | 1,827,258 | 14.40% | 162,296,170 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.70% | 0.01% | 1,597,002 | 1,597,002 | 100.00% | 17,886,422 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 2.98% | 0.07% | 6,824,517 | 1,442,799 | 26.81% | 76,298,100 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.65% | 0.03% | 1,494,739 | 1,435,397 | 2418.86% | 16,711,182 | Jun 30, 2024 |
| MORGAN STANLEY | 2.01% | 0.00% | 4,598,487 | 781,763 | 20.48% | 51,411,084 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.32% | 0.01% | 723,582 | 723,582 | 100.00% | 8,089,646 | Jun 30, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.29% | 0.01% | 665,058 | 599,100 | 908.31% | 7,435,000 | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 0.25% | 0.02% | 578,500 | 578,500 | 100.00% | 6,467,630 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.13% | 0.05% | 2,582,135 | 575,100 | 28.65% | 28,868,269 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.28% | 0.00% | 641,038 | 549,357 | 599.20% | 7,166,805 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.22% | 0.09% | 510,642 | 510,642 | 100.00% | 5,708,978 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.35% | 0.04% | 791,791 | 466,551 | 143.45% | 8,852,223 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.23% | 0.01% | 523,747 | 452,585 | 635.99% | 5,855,491 | Jun 30, 2024 |
| 1832 ASSET MANAGEMENT L.P. | 0.26% | 0.01% | 587,900 | 451,700 | 331.64% | 6,572,722 | Jun 30, 2024 |
| SEGALL BRYANT & HAMILL, LLC | 0.20% | 0.09% | 451,275 | 451,275 | 100.00% | 5,045,255 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.32% | 0.33% | 3,028,667 | 447,743 | 17.35% | 33,860,497 | Jun 30, 2024 |
| BLACKROCK INC. | 8.15% | 0.00% | 18,644,711 | 445,434 | 2.45% | 208,447,868 | Jun 30, 2024 |
As of Jun 30 2024, ADMA Biologics's largest institutional buyer is INVESCO LTD.. The company purchased 5.37M stocks of ADMA, valued at $147.25M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 1.21% | 0.74% | 2,771,000 | -3,662,369 | -56.93% | 30,979,780 | Jun 30, 2024 |
| STATE STREET CORP | 3.52% | 0.00% | 8,059,930 | -2,493,423 | -23.63% | 90,110,017,000 | Jun 30, 2024 |
| OPHIR ASSET MANAGEMENT PTY LTD | 0.80% | 3.63% | 1,831,330 | -1,597,987 | -46.60% | 20,474,269 | Jun 30, 2024 |
| STONEPINE CAPITAL MANAGEMENT, LLC | 0.82% | 19.20% | 1,870,000 | -1,556,882 | -45.43% | 20,906,600 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 3.90% | 0.03% | 8,925,138 | -1,536,238 | -14.68% | 99,783,044 | Jun 30, 2024 |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | - | - | - | -1,528,601 | -100.00% | - | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 2.65% | 0.04% | 6,054,317 | -1,074,194 | -15.07% | 67,687,279 | Jun 30, 2024 |
| MAGNETAR FINANCIAL LLC | 1.62% | 0.87% | 3,712,258 | -947,120 | -20.33% | 41,503,044 | Jun 30, 2024 |
| MESIROW INSTITUTIONAL INVESTMENT MANAGEMENT, INC. | 0.77% | 1.72% | 1,755,455 | -853,827 | -32.72% | 19,625,987 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.41% | 0.00% | 940,655 | -769,366 | -44.99% | 10,516,523 | Jun 30, 2024 |
| OBERWEIS ASSET MANAGEMENT INC/ | 0.89% | 1.40% | 2,040,700 | -750,000 | -26.88% | 22,815,026 | Jun 30, 2024 |
| AWM INVESTMENT COMPANY, INC. | 2.23% | 7.70% | 5,097,625 | -617,257 | -10.80% | 56,991,447 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.20% | 0.04% | 463,685 | -567,758 | -55.05% | 5,183,997 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.38% | 0.01% | 3,157,960 | -440,076 | -12.23% | 35,304,684 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.12% | 0.01% | 279,877 | -402,388 | -58.98% | 3,129,025 | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | 0.07% | 0.00% | 155,892 | -331,884 | -68.04% | 1,742,873 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.22% | 0.13% | 493,311 | -293,496 | -37.30% | 5,515,217 | Jun 30, 2024 |
| ZACKS INVESTMENT MANAGEMENT | - | - | - | -282,846 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.03% | 0.02% | 77,105 | -259,767 | -77.11% | 862,034 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 0.04% | 0.01% | 88,000 | -248,000 | -73.81% | 983,840 | Jun 30, 2024 |
As of Jun 30 2024, ADMA Biologics's biggest institutional seller is PERCEPTIVE ADVISORS LLC. The company sold -3.66M shares of ADMA, valued at $30.98M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BANK OF MONTREAL /CAN/ | 0.70% | 0.01% | 1,597,002 | 1,597,002 | 100.00% | 17,886,422 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.32% | 0.01% | 723,582 | 723,582 | 100.00% | 8,089,646 | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 0.25% | 0.02% | 578,500 | 578,500 | 100.00% | 6,467,630 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.22% | 0.09% | 510,642 | 510,642 | 100.00% | 5,708,978 | Jun 30, 2024 |
| SEGALL BRYANT & HAMILL, LLC | 0.20% | 0.09% | 451,275 | 451,275 | 100.00% | 5,045,255 | Jun 30, 2024 |
| MIURA GLOBAL MANAGEMENT, LLC | 0.13% | 3.27% | 300,000 | 300,000 | 100.00% | 3,354,000 | Jun 30, 2024 |
| CANADA PENSION PLAN INVESTMENT BOARD | 0.11% | 0.00% | 260,200 | 260,200 | 100.00% | 2,909,036 | Jun 30, 2024 |
| STATE OF NEW JERSEY COMMON PENSION FUND D | 0.09% | 0.01% | 197,856 | 197,856 | 100.00% | 2,212,030 | Jun 30, 2024 |
| SEVEN EIGHT CAPITAL, LP | 0.08% | 0.21% | 178,203 | 178,203 | 100.00% | 1,992,310 | Jun 30, 2024 |
| BRANT POINT INVESTMENT MANAGEMENT LLC | 0.05% | 0.13% | 124,626 | 124,626 | 100.00% | 1,393,319 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.01% | 121,159 | 121,159 | 100.00% | 1,354,558 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 117,919 | 117,919 | 100.00% | 1,315,911 | Jun 30, 2024 |
| ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. | 0.05% | 0.00% | 111,084 | 111,084 | 100.00% | 1,241,919 | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 0.04% | 0.00% | 80,750 | 80,750 | 100.00% | 902,785 | Jun 30, 2024 |
| TOROSO INVESTMENTS, LLC | 0.03% | 0.01% | 72,044 | 72,044 | 100.00% | 805,451 | Jun 30, 2024 |
| VERDAD ADVISERS, LP | 0.02% | 0.63% | 49,018 | 49,018 | 100.00% | 548,021 | Jun 30, 2024 |
| BAADER BANK AKTIENGESELLSCHAFT | 0.02% | 0.03% | 46,000 | 46,000 | 100.00% | 514,280 | Jun 30, 2024 |
| GEOWEALTH MANAGEMENT, LLC | 0.02% | 0.02% | 39,354 | 39,354 | 100.00% | 439,977 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.01% | 0.02% | 34,055 | 34,055 | 100.00% | 380,735 | Jun 30, 2024 |
| ROMAN BUTLER FULLERTON & CO | 0.01% | 0.12% | 31,505 | 31,505 | 100.00% | 378,060 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.01% | 0.17% | 28,787 | 28,787 | 100.00% | 321,839 | Jun 30, 2024 |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 0.01% | 0.00% | 20,627 | 20,627 | 100.00% | 231,000 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.01% | 0.05% | 20,532 | 20,532 | 100.00% | 229,550 | Jun 30, 2024 |
| CLEARSTEAD ADVISORS, LLC | 0.01% | 0.00% | 20,000 | 20,000 | 100.00% | 223,600 | Jun 30, 2024 |
| FOX RUN MANAGEMENT, L.L.C. | 0.01% | 0.03% | 15,892 | 15,892 | 100.00% | 177,673 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.01% | 0.00% | 14,896 | 14,896 | 100.00% | 166,537 | Jun 30, 2024 |
| SAVANT CAPITAL, LLC | 0.01% | 0.00% | 13,641 | 13,641 | 100.00% | 152,507 | Jun 30, 2024 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 0.01% | 0.00% | 13,185 | 13,185 | 100.00% | 147,408 | Jun 30, 2024 |
| COOKSON PEIRCE & CO INC | 0.01% | 0.01% | 13,000 | 13,000 | 100.00% | 145,340 | Jun 30, 2024 |
| VONTOBEL HOLDING LTD. | 0.01% | 0.00% | 12,755 | 12,755 | 100.00% | 142,601 | Jun 30, 2024 |
| NEUBERGER BERMAN GROUP LLC | 0.01% | 0.00% | 12,247 | 12,247 | 100.00% | 136,922 | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | 0.01% | 0.00% | 12,122 | 12,122 | 100.00% | 135,524 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.00% | 0.00% | 11,246 | 11,246 | 100.00% | 125,730 | Jun 30, 2024 |
| TRINITYPOINT WEALTH, LLC | 0.00% | 0.02% | 10,841 | 10,841 | 100.00% | 121,202 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.00% | 0.00% | 8,357 | 8,357 | 100.00% | 93,000 | Jun 30, 2024 |
| KBC GROUP NV | 0.00% | 0.00% | 6,550 | 6,550 | 100.00% | 73,000 | Jun 30, 2024 |
| USA FINANCIAL PORTFORMULAS CORP | 0.00% | 0.01% | 6,278 | 6,278 | 100.00% | 70,188 | Jun 30, 2024 |
| QUEST PARTNERS LLC | 0.00% | 0.00% | 2,630 | 2,630 | 100.00% | 29,403 | Jun 30, 2024 |
| OPTIVER HOLDING B.V. | 0.00% | - | 2,156 | 2,156 | 100.00% | 24,104 | Jun 30, 2024 |
| QUARRY LP | 0.00% | 0.01% | 2,156 | 2,156 | 100.00% | 24,104 | Jun 30, 2024 |
| COPPELL ADVISORY SOLUTIONS LLC | 0.00% | 0.00% | 1,788 | 1,788 | 100.00% | 19,990 | Jun 30, 2024 |
| CULLEN/FROST BANKERS, INC. | 0.00% | 0.00% | 842 | 842 | 100.00% | 9,414 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 782 | 782 | 100.00% | 8,743 | Jun 30, 2024 |
| TRUE WEALTH DESIGN, LLC | 0.00% | 0.00% | 700 | 700 | 100.00% | 7,826 | Jun 30, 2024 |
| HUNTINGTON NATIONAL BANK | 0.00% | - | 240 | 240 | 100.00% | 2,683 | Jun 30, 2024 |
| LINDBROOK CAPITAL, LLC | 0.00% | 0.00% | 240 | 240 | 100.00% | 2,683 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 213 | 213 | 100.00% | 2,381 | Jun 30, 2024 |
| ABICH FINANCIAL WEALTH MANAGEMENT LLC | 0.00% | 0.00% | 177 | 177 | 100.00% | 1,979 | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | 0.00% | 0.00% | 136 | 136 | 100.00% | 1,670 | Jun 30, 2024 |
| COVESTOR LTD | 0.00% | 0.00% | 128 | 128 | 100.00% | 1,000 | Jun 30, 2024 |
| BLEAKLEY FINANCIAL GROUP, LLC | - | - | 100 | 100 | 100.00% | 634 | Jun 30, 2024 |
| ANCORA ADVISORS, LLC | - | - | 100 | 100 | 100.00% | 1,118 | Jun 30, 2024 |
ADMA Biologics's largest new institutional shareholder by number of shares is BANK OF MONTREAL /CAN/, purchased 1.60M shares, valued at $17.89M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | - | - | - | -1,528,601 | -100.00% | - | Jun 30, 2024 |
| ZACKS INVESTMENT MANAGEMENT | - | - | - | -282,846 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -106,841 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -105,057 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -98,656 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -54,859 | -100.00% | - | Jun 30, 2024 |
| MAVEN SECURITIES LTD | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -25,598 | -100.00% | - | Jun 30, 2024 |
| AXQ CAPITAL, LP | - | - | - | -19,800 | -100.00% | - | Jun 30, 2024 |
| PRISM ADVISORS, INC. | - | - | - | -19,404 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -16,117 | -100.00% | - | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | - | - | - | -11,453 | -100.00% | - | Jun 30, 2024 |
| BEACON POINTE ADVISORS, LLC | - | - | - | -10,653 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -10,618 | -100.00% | - | Jun 30, 2024 |
| HEADLANDS TECHNOLOGIES LLC | - | - | - | -2,584 | -100.00% | - | Jun 30, 2024 |
| GAME PLAN FINANCIAL ADVISORS, LLC | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
| OLD POINT TRUST & FINANCIAL SERVICES N A | - | - | - | -500 | -100.00% | - | Jun 30, 2024 |
ADMA Biologics's largest sold out institutional shareholder by shares sold is VELAN CAPITAL INVESTMENT MANAGEMENT LP, sold -1.53M shares, valued at -, as of undefined.
ADMA Biologics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| NUVEEN INVESTMENT TRUST | 5.45% | 3,062,061 | 16,755 | 0.55% | Mar 31, 2024 |
| OBERWEIS FUNDS | 2.73% | 2,790,700 | 80,000 | 2.95% | Mar 31, 2024 |
| ALGER FUNDS II | 1.09% | 247,443 | - | - | Jan 31, 2024 |
| ALGER INSTITUTIONAL FUNDS | 0.77% | 199,296 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.62% | 1,470,100 | - | - | Mar 28, 2024 |
| ALGER PORTFOLIOS | 0.61% | 228,093 | - | - | Dec 31, 2023 |
| ALGER FUNDS | 0.53% | 506,775 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.33% | 3,332,781 | 1,211,475 | 57.11% | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.30% | 156,471 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.10% | 247,593 | -34,099 | -12.11% | Jan 31, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.10% | 3,047,347 | 299,042 | 10.88% | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL FUNDS | 0.07% | 54,715 | 54,715 | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.06% | 376,347 | -9,141 | -2.37% | Mar 31, 2024 |
| Humankind Benefit Corp | 0.06% | 1,314 | 56 | 4.45% | Dec 31, 2023 |
| ETFis Series Trust I | 0.06% | 80,743 | 2,519 | 3.22% | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.05% | 32,172 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.05% | 663,323 | - | - | Jan 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.05% | 437,264 | - | - | Jan 31, 2024 |
| FORUM FUNDS II | 0.04% | 35,635 | 373 | 1.06% | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.03% | 298,777 | -1,859 | -0.62% | Mar 28, 2024 |
| HUSSMAN INVESTMENT TRUST | 0.02% | 82,000 | - | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.02% | 9,594,820 | -3,077,921 | -24.29% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.02% | 4,828 | - | - | Mar 31, 2024 |
| MASSMUTUAL PREMIER FUNDS | 0.02% | 582,599 | 10,741 | 1.88% | Dec 31, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.02% | 50,892 | - | - | Feb 29, 2024 |
| Federated Hermes Equity Funds | 0.02% | 293,057 | -194,379 | -39.88% | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.01% | 62,415 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.01% | 40,711 | -1,329 | -3.16% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 576,834 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY WORLD MUTUAL FUNDS INC | 0.01% | 135,923 | 11,951 | 9.64% | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 2,007,559 | 89,413 | 4.66% | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.01% | 109,360 | -23,707 | -17.82% | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.01% | 156,211 | 11,803 | 8.17% | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 55,845 | - | - | Aug 31, 2023 |
| Calvert Variable Products, Inc. | 0.01% | 20,929 | - | - | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.01% | 17,424 | -28,484 | -62.05% | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.01% | 448,735 | -2,015 | -0.45% | Feb 29, 2024 |
| OPTIMUM FUND TRUST | 0.01% | 248,614 | -25,622 | -9.34% | Mar 28, 2024 |
| Virtus Investment Trust | 0.00% | 157,268 | - | - | Mar 28, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 131,061 | -10,390 | -7.35% | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 522,639 | 31,391 | 6.39% | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 3,483,514 | -594,055 | -14.57% | Mar 31, 2024 |
| ProFunds | 0.00% | 36,293 | 3,989 | 12.35% | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 3,198,972 | 1,004,673 | 45.79% | Jan 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 725,870 | 47,481 | 7.00% | Feb 29, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 155,606 | -133,689 | -46.21% | Feb 29, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 11,914 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 11,546 | 1,335 | 13.07% | Mar 31, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 56,064 | 56,064 | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 71,162 | -15,333 | -17.73% | Mar 31, 2024 |
| AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC | 0.00% | 28,874 | 14,510 | 101.02% | Jan 31, 2024 |
| Global X Funds | 0.00% | 91,204 | - | - | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 1,106,180 | 34,610 | 3.23% | Feb 29, 2024 |
| RBB FUND, INC. | 0.00% | 167,983 | - | - | Feb 29, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 132,589 | -70,695 | -34.78% | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 679,997 | 103,450 | 17.94% | Jan 31, 2024 |
| FundVantage Trust | 0.00% | 19,917 | 19,138 | 2456.74% | Mar 28, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 11,800 | 11,800 | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 76,100 | -200 | -0.26% | Mar 31, 2024 |
| LAZARD FUNDS INC | 0.00% | 46,193 | -1,743 | -3.64% | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 157,514 | -7,964 | -4.81% | Mar 28, 2024 |
| MML Series Investment Fund II | 0.00% | 198,244 | - | - | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 12,014 | 780 | 6.94% | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 496 | - | - | Apr 30, 2021 |
| Federated Hermes Global Allocation Fund | 0.00% | 7,361 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 2,149,506 | 2,421 | 0.11% | Jan 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 32,189 | -169,225 | -84.02% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 13,508 | 1,264 | 10.32% | Mar 31, 2024 |
| Investment Managers Series Trust II | 0.00% | 7,414 | 6,819 | 1146.05% | Mar 31, 2024 |
| AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS) | 0.00% | 1,376,457 | 35,404 | 2.64% | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 179,559 | 119,591 | 199.42% | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 9,562,664 | -369,155 | -3.72% | Mar 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 172,960 | 114,835 | 197.57% | Jan 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 44,667 | 17,096 | 62.01% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 580,055 | 23,507 | 4.22% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 960,338 | 123,887 | 14.81% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 1,920 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 58,004 | 24,253 | 71.86% | Jan 31, 2024 |
| CARILLON SERIES TRUST | 0.00% | 23,560 | 23,560 | - | Mar 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 48,700 | 8,700 | 21.75% | Mar 31, 2024 |
| AMG FUNDS III | 0.00% | 1,965 | - | - | Mar 28, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 43,482 | 17,175 | 65.29% | Mar 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 82,408 | - | - | Feb 29, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 34,604 | -1,341 | -3.73% | Feb 29, 2024 |
| VALIC Co I | 0.00% | 81,808 | 640 | 0.79% | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 8,246 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 33,821 | -124,015 | -78.57% | Mar 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 100,341 | -21,722 | -17.80% | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 953 | - | - | Dec 31, 2023 |
| Meeder Funds | 0.00% | 1,119 | - | - | Mar 31, 2024 |
| Northern Lights Fund Trust IV | 0.00% | 75,632 | -16,665 | -18.06% | Feb 29, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 24,759 | - | - | Mar 28, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 6,500 | -900 | -12.16% | Mar 28, 2024 |
| PROSHARES TRUST | 0.00% | 48,118 | 6,560 | 15.79% | Feb 29, 2024 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 55,353 | 55,353 | - | Feb 29, 2024 |
| PGIM ETF TRUST | 0.00% | 10,384 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 464,676 | -240,877 | -34.14% | Dec 31, 2023 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 8,156 | - | - | Dec 31, 2023 |
| SPDR SERIES TRUST | 0.00% | 5,684,254 | 827,245 | 17.03% | Mar 31, 2024 |
| THRIVENT MUTUAL FUNDS | 0.00% | 11,542 | - | - | Mar 28, 2024 |
ADMA Biologics's largest mutual fund holder by % of total assets is "NUVEEN INVESTMENT TRUST", owning 3.06M shares, compromising 5.45% of its total assets.
ADMA Biologics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 243 | 11.98% |
| 31 Mar, 24 | 217 | 16.67% |
| 31 Dec, 23 | 186 | -1.59% |
| 30 Sep, 23 | 189 | 5.00% |
| 30 Jun, 23 | 180 | 9.76% |
| 31 Mar, 23 | 164 | -2.38% |
| 31 Dec, 22 | 168 | 27.27% |
| 30 Sep, 22 | 132 | 15.79% |
| 30 Jun, 22 | 114 | 6.54% |
| 31 Mar, 22 | 107 | 13.83% |
| 31 Dec, 21 | 94 | 18.99% |
| 30 Sep, 21 | 79 | -16.84% |
| 30 Jun, 21 | 95 | -13.64% |
| 31 Mar, 21 | 110 | 10.00% |
| 31 Dec, 20 | 100 | -0.99% |
| 30 Sep, 20 | 101 | 1.00% |
| 30 Jun, 20 | 100 | 5.26% |
| 31 Mar, 20 | 95 | 23.38% |
| 31 Dec, 19 | 77 | 4.05% |
| 30 Sep, 19 | 74 | 5.71% |
| 30 Jun, 19 | 70 | 20.69% |
| 31 Mar, 19 | 58 | 16.00% |
| 31 Dec, 18 | 50 | -12.28% |
| 30 Sep, 18 | 57 | 3.64% |
| 30 Jun, 18 | 55 | 61.76% |
| 31 Mar, 18 | 34 | 47.83% |
| 31 Dec, 17 | 23 | 35.29% |
| 30 Sep, 17 | 17 | -10.53% |
| 30 Jun, 17 | 19 | 5.56% |
| 31 Mar, 17 | 18 | 5.88% |
| 31 Dec, 16 | 17 | -5.56% |
| 30 Sep, 16 | 18 | -33.33% |
| 30 Jun, 16 | 27 | 22.73% |
| 31 Mar, 16 | 22 | -12.00% |
| 31 Dec, 15 | 25 | 8.70% |
| 30 Sep, 15 | 23 | - |
| 30 Jun, 15 | 23 | 27.78% |
| 31 Mar, 15 | 18 | 50.00% |
| 31 Dec, 14 | 12 | 1100.00% |
| 30 Sep, 14 | 1 | - |
| 30 Jun, 14 | 1 | - |
As of 30 Jun 24, 243 institutions are holding ADMA Biologics's shares, representing an increase of 11.98% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 178,468,880 | 2.29% |
| 31 Mar, 24 | 174,477,070 | 3.15% |
| 31 Dec, 23 | 169,142,481 | -1.14% |
| 30 Sep, 23 | 171,085,631 | 3.40% |
| 30 Jun, 23 | 165,456,815 | 0.10% |
| 31 Mar, 23 | 165,298,236 | 8.31% |
| 31 Dec, 22 | 152,609,958 | 17.68% |
| 30 Sep, 22 | 129,681,699 | 8.77% |
| 30 Jun, 22 | 119,226,666 | 13.69% |
| 31 Mar, 22 | 104,867,065 | 7.89% |
| 31 Dec, 21 | 97,196,143 | 115.49% |
| 30 Sep, 21 | 45,103,988 | 5.40% |
| 30 Jun, 21 | 42,793,700 | -11.63% |
| 31 Mar, 21 | 48,426,437 | 7.27% |
| 31 Dec, 20 | 45,142,687 | -2.36% |
| 30 Sep, 20 | 46,231,989 | -5.25% |
| 30 Jun, 20 | 48,796,011 | 0.71% |
| 31 Mar, 20 | 48,454,316 | 49.26% |
| 31 Dec, 19 | 32,463,005 | -12.70% |
| 30 Sep, 19 | 37,185,537 | 6.13% |
| 30 Jun, 19 | 35,037,173 | 57.17% |
| 31 Mar, 19 | 22,292,637 | -9.72% |
| 31 Dec, 18 | 24,692,426 | -7.35% |
| 30 Sep, 18 | 26,649,967 | 4.38% |
| 30 Jun, 18 | 25,532,526 | 50.59% |
| 31 Mar, 18 | 16,954,992 | -0.43% |
| 31 Dec, 17 | 17,028,284 | 101.44% |
| 30 Sep, 17 | 8,453,450 | -5.14% |
| 30 Jun, 17 | 8,911,060 | -3.44% |
| 31 Mar, 17 | 9,228,220 | -1.54% |
| 31 Dec, 16 | 9,372,549 | -1.09% |
| 30 Sep, 16 | 9,476,278 | -0.49% |
| 30 Jun, 16 | 9,523,198 | 13.35% |
| 31 Mar, 16 | 8,401,575 | -0.25% |
| 31 Dec, 15 | 8,422,464 | 19.46% |
| 30 Sep, 15 | 7,050,208 | 0.30% |
| 30 Jun, 15 | 7,029,310 | 1.15% |
| 31 Mar, 15 | 6,949,700 | 16.29% |
| 31 Dec, 14 | 5,975,970 | 669.24% |
| 30 Sep, 14 | 776,863 | 16.45% |
| 30 Jun, 14 | 667,099 | - |
ADMA Biologics (ADMA) has 178.47M shares outstanding as of 30 Jun 24, up 2.29% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 77.98% | 1.31% |
| 31 Mar, 24 | 77.21% | 1.37% |
| 31 Dec, 23 | 75.08% | 1.27% |
| 30 Sep, 23 | 76.83% | 1.38% |
| 30 Jun, 23 | 74.56% | 1.34% |
| 31 Mar, 23 | 74.48% | 1.32% |
| 31 Dec, 22 | 75.24% | 1.73% |
| 30 Sep, 22 | 66.03% | 1.79% |
| 30 Jun, 22 | 60.72% | 2.12% |
| 31 Mar, 22 | 53.54% | 1.10% |
| 31 Dec, 21 | 69.64% | 6.13% |
| 30 Sep, 21 | 33.72% | 2.99% |
| 30 Jun, 21 | 33.59% | 1.92% |
| 31 Mar, 21 | 41.87% | 1.92% |
| 31 Dec, 20 | 46.72% | 1.68% |
| 30 Sep, 20 | 52.72% | 1.65% |
| 30 Jun, 20 | 56.51% | 1.31% |
| 31 Mar, 20 | 65.67% | 1.84% |
| 31 Dec, 19 | 59.73% | 1.52% |
| 30 Sep, 19 | 62.69% | 1.39% |
| 30 Jun, 19 | 67.11% | 2.90% |
| 31 Mar, 19 | 48.09% | 1.69% |
| 31 Dec, 18 | 53.27% | 1.61% |
| 30 Sep, 18 | 57.50% | 1.61% |
| 30 Jun, 18 | 59.78% | 4.27% |
| 31 Mar, 18 | 37.41% | 0.68% |
| 31 Dec, 17 | 74.37% | 6.92% |
| 30 Sep, 17 | 32.78% | 1.11% |
| 30 Jun, 17 | 54.25% | 1.06% |
| 31 Mar, 17 | 71.61% | 1.35% |
| 31 Dec, 16 | 72.73% | 1.35% |
| 30 Sep, 16 | 73.54% | 1.19% |
| 30 Jun, 16 | 78.56% | 1.28% |
| 31 Mar, 16 | 78.44% | 1.27% |
| 31 Dec, 15 | 78.64% | 1.81% |
| 30 Sep, 15 | 65.84% | 1.53% |
| 30 Jun, 15 | 65.66% | 1.32% |
| 31 Mar, 15 | 70.52% | 1.70% |
| 31 Dec, 14 | 64.31% | 92.01% |
| 30 Sep, 14 | 8.36% | 16.22% |
| 30 Jun, 14 | 7.18% | - |
As of 30 Jun 24, ADMA Biologics is held by 77.98% institutional shareholders, representing a 1.31% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 141 | 2.17% |
| 31 Mar, 24 | 138 | 50.00% |
| 31 Dec, 23 | 92 | -16.36% |
| 30 Sep, 23 | 110 | 25.00% |
| 30 Jun, 23 | 88 | -2.22% |
| 31 Mar, 23 | 90 | -9.09% |
| 31 Dec, 22 | 99 | 43.48% |
| 30 Sep, 22 | 69 | 2.99% |
| 30 Jun, 22 | 67 | 17.54% |
| 31 Mar, 22 | 57 | 14.00% |
| 31 Dec, 21 | 50 | 92.31% |
| 30 Sep, 21 | 26 | -29.73% |
| 30 Jun, 21 | 37 | -36.21% |
| 31 Mar, 21 | 58 | 7.41% |
| 31 Dec, 20 | 54 | 20.00% |
| 30 Sep, 20 | 45 | -15.09% |
| 30 Jun, 20 | 53 | -23.19% |
| 31 Mar, 20 | 69 | 43.75% |
| 31 Dec, 19 | 48 | - |
| 30 Sep, 19 | 48 | -2.04% |
| 30 Jun, 19 | 49 | 75.00% |
| 31 Mar, 19 | 28 | 16.67% |
| 31 Dec, 18 | 24 | -20.00% |
| 30 Sep, 18 | 30 | -38.78% |
| 30 Jun, 18 | 49 | 122.73% |
| 31 Mar, 18 | 22 | 15.79% |
| 31 Dec, 17 | 19 | 171.43% |
| 30 Sep, 17 | 7 | 40.00% |
| 30 Jun, 17 | 5 | -28.57% |
| 31 Mar, 17 | 7 | 75.00% |
| 31 Dec, 16 | 4 | -50.00% |
| 30 Sep, 16 | 8 | -55.56% |
| 30 Jun, 16 | 18 | 38.46% |
| 31 Mar, 16 | 13 | - |
| 31 Dec, 15 | 13 | 8.33% |
| 30 Sep, 15 | 12 | -7.69% |
| 30 Jun, 15 | 13 | -7.14% |
| 31 Mar, 15 | 14 | 16.67% |
| 31 Dec, 14 | 12 | 1100.00% |
| 30 Sep, 14 | 1 | - |
| 30 Jun, 14 | 1 | - |
141 institutional shareholders have increased their position in ADMA stock as of 30 Jun 24 compared to 138 in the previous quarter (a 2.17% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 79 | 51.92% |
| 31 Mar, 24 | 52 | -10.34% |
| 31 Dec, 23 | 58 | 26.09% |
| 30 Sep, 23 | 46 | -24.59% |
| 30 Jun, 23 | 61 | 52.50% |
| 31 Mar, 23 | 40 | 8.11% |
| 31 Dec, 22 | 37 | 5.71% |
| 30 Sep, 22 | 35 | 45.83% |
| 30 Jun, 22 | 24 | 4.35% |
| 31 Mar, 22 | 23 | 4.55% |
| 31 Dec, 21 | 22 | -15.38% |
| 30 Sep, 21 | 26 | -25.71% |
| 30 Jun, 21 | 35 | 25.00% |
| 31 Mar, 21 | 28 | 27.27% |
| 31 Dec, 20 | 22 | -42.11% |
| 30 Sep, 20 | 38 | 35.71% |
| 30 Jun, 20 | 28 | 115.38% |
| 31 Mar, 20 | 13 | -13.33% |
| 31 Dec, 19 | 15 | 36.36% |
| 30 Sep, 19 | 11 | 37.50% |
| 30 Jun, 19 | 8 | -27.27% |
| 31 Mar, 19 | 11 | -31.25% |
| 31 Dec, 18 | 16 | 33.33% |
| 30 Sep, 18 | 12 | 300.00% |
| 30 Jun, 18 | 3 | -50.00% |
| 31 Mar, 18 | 6 | 200.00% |
| 31 Dec, 17 | 2 | -33.33% |
| 30 Sep, 17 | 3 | -57.14% |
| 30 Jun, 17 | 7 | 75.00% |
| 31 Mar, 17 | 4 | -33.33% |
| 31 Dec, 16 | 6 | 50.00% |
| 30 Sep, 16 | 4 | - |
| 30 Jun, 16 | 4 | 33.33% |
| 31 Mar, 16 | 3 | -50.00% |
| 31 Dec, 15 | 6 | 100.00% |
| 30 Sep, 15 | 3 | -25.00% |
| 30 Jun, 15 | 4 | 100.00% |
| 31 Mar, 15 | 2 | - |
| 31 Dec, 14 | - | - |
| 30 Sep, 14 | - | - |
| 30 Jun, 14 | - | - |
79 institutional shareholders have reduced their position in ADMA stock as of 30 Jun 24 compared to 52 in the previous quarter (a 51.92% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 243 | 11.98% | 178,468,880 | 2.29% | 77.98% | 1.31% | 141 | 2.17% | 79 | 51.92% |
| 31 Mar, 24 | 217 | 16.67% | 174,477,070 | 3.15% | 77.21% | 1.37% | 138 | 50.00% | 52 | -10.34% |
| 31 Dec, 23 | 186 | -1.59% | 169,142,481 | -1.14% | 75.08% | 1.27% | 92 | -16.36% | 58 | 26.09% |
| 30 Sep, 23 | 189 | 5.00% | 171,085,631 | 3.40% | 76.83% | 1.38% | 110 | 25.00% | 46 | -24.59% |
| 30 Jun, 23 | 180 | 9.76% | 165,456,815 | 0.10% | 74.56% | 1.34% | 88 | -2.22% | 61 | 52.50% |
| 31 Mar, 23 | 164 | -2.38% | 165,298,236 | 8.31% | 74.48% | 1.32% | 90 | -9.09% | 40 | 8.11% |
| 31 Dec, 22 | 168 | 27.27% | 152,609,958 | 17.68% | 75.24% | 1.73% | 99 | 43.48% | 37 | 5.71% |
| 30 Sep, 22 | 132 | 15.79% | 129,681,699 | 8.77% | 66.03% | 1.79% | 69 | 2.99% | 35 | 45.83% |
| 30 Jun, 22 | 114 | 6.54% | 119,226,666 | 13.69% | 60.72% | 2.12% | 67 | 17.54% | 24 | 4.35% |
| 31 Mar, 22 | 107 | 13.83% | 104,867,065 | 7.89% | 53.54% | 1.10% | 57 | 14.00% | 23 | 4.55% |
| 31 Dec, 21 | 94 | 18.99% | 97,196,143 | 115.49% | 69.64% | 6.13% | 50 | 92.31% | 22 | -15.38% |
| 30 Sep, 21 | 79 | -16.84% | 45,103,988 | 5.40% | 33.72% | 2.99% | 26 | -29.73% | 26 | -25.71% |
| 30 Jun, 21 | 95 | -13.64% | 42,793,700 | -11.63% | 33.59% | 1.92% | 37 | -36.21% | 35 | 25.00% |
| 31 Mar, 21 | 110 | 10.00% | 48,426,437 | 7.27% | 41.87% | 1.92% | 58 | 7.41% | 28 | 27.27% |
| 31 Dec, 20 | 100 | -0.99% | 45,142,687 | -2.36% | 46.72% | 1.68% | 54 | 20.00% | 22 | -42.11% |
| 30 Sep, 20 | 101 | 1.00% | 46,231,989 | -5.25% | 52.72% | 1.65% | 45 | -15.09% | 38 | 35.71% |
| 30 Jun, 20 | 100 | 5.26% | 48,796,011 | 0.71% | 56.51% | 1.31% | 53 | -23.19% | 28 | 115.38% |
| 31 Mar, 20 | 95 | 23.38% | 48,454,316 | 49.26% | 65.67% | 1.84% | 69 | 43.75% | 13 | -13.33% |
| 31 Dec, 19 | 77 | 4.05% | 32,463,005 | -12.70% | 59.73% | 1.52% | 48 | - | 15 | 36.36% |
| 30 Sep, 19 | 74 | 5.71% | 37,185,537 | 6.13% | 62.69% | 1.39% | 48 | -2.04% | 11 | 37.50% |
| 30 Jun, 19 | 70 | 20.69% | 35,037,173 | 57.17% | 67.11% | 2.90% | 49 | 75.00% | 8 | -27.27% |
| 31 Mar, 19 | 58 | 16.00% | 22,292,637 | -9.72% | 48.09% | 1.69% | 28 | 16.67% | 11 | -31.25% |
| 31 Dec, 18 | 50 | -12.28% | 24,692,426 | -7.35% | 53.27% | 1.61% | 24 | -20.00% | 16 | 33.33% |
| 30 Sep, 18 | 57 | 3.64% | 26,649,967 | 4.38% | 57.50% | 1.61% | 30 | -38.78% | 12 | 300.00% |
| 30 Jun, 18 | 55 | 61.76% | 25,532,526 | 50.59% | 59.78% | 4.27% | 49 | 122.73% | 3 | -50.00% |
| 31 Mar, 18 | 34 | 47.83% | 16,954,992 | -0.43% | 37.41% | 0.68% | 22 | 15.79% | 6 | 200.00% |
| 31 Dec, 17 | 23 | 35.29% | 17,028,284 | 101.44% | 74.37% | 6.92% | 19 | 171.43% | 2 | -33.33% |
| 30 Sep, 17 | 17 | -10.53% | 8,453,450 | -5.14% | 32.78% | 1.11% | 7 | 40.00% | 3 | -57.14% |
| 30 Jun, 17 | 19 | 5.56% | 8,911,060 | -3.44% | 54.25% | 1.06% | 5 | -28.57% | 7 | 75.00% |
| 31 Mar, 17 | 18 | 5.88% | 9,228,220 | -1.54% | 71.61% | 1.35% | 7 | 75.00% | 4 | -33.33% |
| 31 Dec, 16 | 17 | -5.56% | 9,372,549 | -1.09% | 72.73% | 1.35% | 4 | -50.00% | 6 | 50.00% |
| 30 Sep, 16 | 18 | -33.33% | 9,476,278 | -0.49% | 73.54% | 1.19% | 8 | -55.56% | 4 | - |
| 30 Jun, 16 | 27 | 22.73% | 9,523,198 | 13.35% | 78.56% | 1.28% | 18 | 38.46% | 4 | 33.33% |
| 31 Mar, 16 | 22 | -12.00% | 8,401,575 | -0.25% | 78.44% | 1.27% | 13 | - | 3 | -50.00% |
| 31 Dec, 15 | 25 | 8.70% | 8,422,464 | 19.46% | 78.64% | 1.81% | 13 | 8.33% | 6 | 100.00% |
| 30 Sep, 15 | 23 | - | 7,050,208 | 0.30% | 65.84% | 1.53% | 12 | -7.69% | 3 | -25.00% |
| 30 Jun, 15 | 23 | 27.78% | 7,029,310 | 1.15% | 65.66% | 1.32% | 13 | -7.14% | 4 | 100.00% |
| 31 Mar, 15 | 18 | 50.00% | 6,949,700 | 16.29% | 70.52% | 1.70% | 14 | 16.67% | 2 | - |
| 31 Dec, 14 | 12 | 1100.00% | 5,975,970 | 669.24% | 64.31% | 92.01% | 12 | 1100.00% | - | - |
| 30 Sep, 14 | 1 | - | 776,863 | 16.45% | 8.36% | 16.22% | 1 | - | - | - |
| 30 Jun, 14 | 1 | - | 667,099 | - | 7.18% | - | 1 | - | - | - |
ADMA Biologics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of ADMA Biologics's stock was made by Kestenberg-Messina Kaitlin M. on Jul 26 2024, selling 2,502 shares at $13.58 per share (valued at $33.98K).
ADMA Biologics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | 3 | 66.67% |
| Q2 2024 | 2 | 17 | 11.76% |
| Q1 2024 | 14 | 15 | 93.33% |
| Q4 2023 | - | 2 | - |
| Q3 2023 | 14 | 23 | 60.87% |
| Q2 2023 | - | 2 | - |
| Q1 2023 | 16 | 12 | 133.33% |
| Q4 2022 | 3 | - | - |
| Q3 2022 | - | 2 | - |
| Q2 2022 | - | 2 | - |
| Q1 2022 | 19 | 2 | 950.00% |
| Q4 2021 | 6 | 1 | 600.00% |
| Q3 2021 | 4 | 10 | 40.00% |
| Q1 2021 | 11 | - | - |
| Q3 2020 | 18 | - | - |
| Q2 2020 | 1 | - | - |
| Q1 2020 | 32 | - | - |
| Q2 2019 | 8 | 1 | 800.00% |
| Q1 2019 | 11 | - | - |
| Q2 2018 | 13 | 2 | 650.00% |
2 total buy trades, and 3 total sell trades (buy/sell ratio of 0.67%) were made by ADMA Biologics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | 1 | - |
| Q1 2024 | - | 5 | - |
| Q4 2023 | - | - | - |
| Q3 2023 | 2 | 6 | 33.33% |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | 3 | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 5 | - | - |
| Q3 2021 | - | 10 | - |
| Q1 2021 | - | - | - |
| Q3 2020 | 18 | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | 9 | - | - |
| Q2 2019 | 8 | 1 | 800.00% |
| Q1 2019 | 1 | - | - |
| Q2 2018 | 7 | 2 | 350.00% |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of ADMA Biologics's stocks.
ADMA Biologics Peer Ownership
| Ticker | Company |
|---|---|
| PLRX | Pliant Therapeutics, Inc. |
| SANA | Sana Biotechnology, Inc. |
| BCRX | BioCryst Pharmaceuticals, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| AKBA | Akebia Therapeutics, Inc. |
| ATRA | Atara Biotherapeutics, Inc. |
| FATE | Fate Therapeutics, Inc. |
| RCUS | Arcus Biosciences, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| MCRB | Seres Therapeutics, Inc. |
| TNXP | Tonix Pharmaceuticals Holding Corp. |
| CRBU | Caribou Biosciences, Inc. |
| ANTX | AN2 Therapeutics, Inc. |
| ACLX | Arcellx, Inc. |
| TFFP | TFF Pharmaceuticals, Inc. |
| ETNB | 89bio, Inc. |
| VXRT | Vaxart, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| CDTX | Cidara Therapeutics, Inc. |
| INMB | INmune Bio, Inc. |
| MDGL | Madrigal Pharmaceuticals, Inc. |
ADMA Ownership FAQ
Who Owns ADMA Biologics?
ADMA Biologics is owned by institutional shareholders (77.98%), insiders (2.58%), and public (19.44%). The largest institutional shareholder of ADMA Biologics is BLACKROCK INC. (8.15% of total shares) and the top mutual fund owner is NUVEEN INVESTMENT TRUST (5.45% of total shares).
Who are the major institutional shareholders of ADMA Biologics?
ADMA Biologics's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, INVESCO LTD., NUVEEN ASSET MANAGEMENT, LLC, and STATE STREET CORP. The top five shareholders own together 27.66% of the company's share outstanding.
How many ADMA Biologics shareholders are there?
As of Jun 2024, there are 243 institutional shareholders of ADMA Biologics.
What percentage of ADMA Biologics is owned by BLACKROCK INC?
BLACKROCK INC owns 18.64M shares of ADMA Biologics, representing 8.15% of the company's total shares outstanding, valued at $208.45M (as of Jun 2024).
What percentage of ADMA Biologics is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 14.52M shares of ADMA Biologics (ADMA), compromising 6.34% of the company, valued at $162.3M.
What percentage of ADMA Biologics is owned by INVESCO LTD?
INVESCO LTD is the third largest holder of ADMA Biologics. The company owns 13.17M of the company's shares outstanding (worth $147.25M).